Transgenic rats: Tools to study the function of the renin-angiotensin system

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue SUPPL. 3, 1996, Pages

  Bader, Michael ^a   Ganten, Detlev ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Adrenal gland; Angiotensinogen; Antihypertensives; Kidney; Renin; Transgenic animals

Indexed keywords

ANGIOTENSIN RECEPTOR; LOSARTAN; LOSARTAN POTASSIUM; REMIKIREN; TELMISARTAN; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RENIN;

ADRENAL GLAND; ANIMAL EXPERIMENT; CARDIOVASCULAR SYSTEM; CONFERENCE PAPER; GENE EXPRESSION; GENE FUNCTION; HYPERTENSION; MORPHOLOGY; NONHUMAN; PLASMA RENIN ACTIVITY; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRANSGENIC ANIMAL; ANIMAL; DOWN REGULATION; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MOUSE; REVIEW; TISSUE DISTRIBUTION;

ANGIOTENSIN II; ANGIOTENSINOGEN; ANIMALS; HUMANS; MODELS, ANIMAL; RATS; RATS, TRANSGENIC; RENIN; RENIN-ANGIOTENSIN SYSTEM; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS, GENETICALLY MODIFIED; ANTIHYPERTENSIVE AGENTS; DOWN-REGULATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HYPERTENSION; MICE; RECEPTORS, ANGIOTENSIN; TISSUE DISTRIBUTION;

EID: 79953161852     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (80)

1. Hackenthal E, Paul M, Ganten D, Taugner R. Morphology, physiology, and molecular biology of renin secretion. Physiol. Rev. 1990; 70: 1067-116.
2. Bader M, Paul M, Fernandez-Alfonso M, Kaling M, Ganten D. Molecular biology and biochemistry of the renin-angiotensin system. In: Swales JD (ed.). Textbook of Hypertension. Blackwell Science, Oxford. 1994; 214-32.
3. Schelling P, Fischer H, Ganten D. Angiotensin and cell growth: A link to cardiovascular hypertrophy? J. Hypertens. 1991; 9: 3-15.
4. Okamoto K, Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn. Circ. J. 1963; 27: 282-93.
5. Dahl LK, Heine M, Tassinari L. Effects of chronic salt ingestion: Evidence that genetic factors play an important role in susceptibility to experimental hypertension. J. Exp. Med. 1962; 115: 1173-90.
6. Bianchi G, Ferrari P, Barber BR. The Milan hypertensive strain. In: de Jong W (ed.). Experimental and Genetic Models of Hypertension. Elsevier Science, Oxford. 1984; 328-49.
7. Vincent M, Sacquet J, Sassard J. The Lyon strains of hypertensive, normotensive and low-blood-pressure rats. In: de Jong W (ed.). Experimental and Genetic Models of Hypertension. Elsevier Science, Oxford. 1984; 314-27.
8. Hilbert P, Lindpaintner K, Beckmann JS et al. Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats. Nature 1991; 353: 521-9.
9. Jacob HJ, Lindpaintner K, Lincoln SE et al. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell 1991; 67: 213-24.
10. Mullins JJ, Mullins LJ. Transgenesis in nonmurine species. Hypertension 1993; 22: 630-3.
11. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 1990; 344: 541-4.
12. Mullins JJ, Sigmund CD, Kane-Haas C, McGowan RA, Gross KW. Expression of the DBA/2J Ren-2 gene in the adrenal gland of transgenic mice. EMBO J. 1989; 8: 4065-72.
13. Lee M, Zhao Y, Peters J et al. Preparation and analysis of transgenic rats expressing the mouse Ren-2 gene. J. Vasc. Med. Biol. 1991; 3: 50-4.
14. Ganten D, Lindpaintner K, Ganten U et al. Transgenic rats: New animal models in hypertension research. Hypertension 1991; 17: 843-55.
15. Sharpe RM, Maguire SM, Saunders PTK et al. Infertility in a transgenic rat due to impairment of cytoplasmic elimination and sperm release from the sertoli cells. Biol. Reprod. 1995; 53: 214-26.
16. Zhao Y, Bader M, Kreutz R et al. Ontogenetic regulation of the mouse Ren-2d renin gene in transgenic hypertensive rats, TGR (mREN2)27. Am. J. Physiol. 1993; 265: E695-707.
17. Bader M, Zhao Y, Sander M et al. Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats. Hypertension 1992; 19: 681-6.
18. Bachmann J, Feldmer M, Ganten U, Stock G, Ganten D. Sexual dimorphism of blood pressure: Possible role of the renin-angiotensin system. J. Steroid Biochem. 1991; 40: 511-15.
19. Peters J, Bader M, Ganten D, Mullins J. Tissue distribution of Ren-2 expression in transgenic rats. In: Berg VB, Bulyzhenkov V, Christen Y, Corvol P (eds). Genetic Approaches to Coronary Heart Disease and Hypertension. Springer Verlag, Heidelberg. 1991; 74-80.
20. Bachmann S, Peters J, Engler E, Ganten D, Mullins J. Transgenic rats carrying the mouse renin gene: Morphological characterization of a low renin hypertension model. Kidney Int. 1992; 41: 24-36.
21. Tokita Y, Yamaguchi T, Franco-Saenz R, Mulrow PJ, Ganten D. Adrenal renin is released into the circulation of the hypertensive transgenic rat TGR(mRen-2)27. Trans. Assoc. Am. Phys. 1992; CV: 123-32.
22. Moriguchi A, Brosnihan KB, Kumagai H, Ganten D, Ferrario CM. Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene. Am. J. Physiol. 1994; 266: R1273-9.
23. Tokita Y, Franco-Saenz R, Reimann EM, Mulrow PJ. Hypertension in transgenic rat TGR(mRen-2)27 may be due to enhanced kinetics of the reaction between mouse renin and rat angioten-sinogen. Hypertension 1994; 23: 422-7.
24. Campbell DJ, Rong P, Kladis A, Rees B, Ganten D, Skinner SL. Angiotensin and bradykinin peptides in the TGR(mRen-2)27 rat. Hypertension 1995; 25: 1014-20.
25. Tokita Y, Franco-Saenz R, Mulrow PJ, Ganten D. Effects of nephrectomy and adrenalectomy on the renin-angiotensin system on transgenic rats TGR(mRen2)27. Endocrinology 1994; 134: 253-7.
26. Peters J, Münter K, Bader M, Hackenthal E, Mullins JJ, Ganten D. Increased adrenal renin in transgenic hypertensive rats, TGR (mREN2)27, and its regulation by cAMP, angiotensin II, and calcium. J. Clin. Invest. 1993; 91: 742-7.
27. Tepel M, Theilmeier G, Bachmann J et al. Increased cytosolic sodium and reduced Na,K-ATPase activity in transgenic rat. Hypertension 1994; 23: 1198-202.
28. Bader M, Wagner J, Lee M, Ganten D. The role of the renin-angiotensin system in cardiovascular disease. Hypertens. Res. 1994; 17: 1-16.
29. Nakamaru M, Misono KS, Naruse M, Workman RJ, Inagami T. A role for the adrenal renin - angiotensin system in the regulation of potassium-stimulated aldosterone production. Endocrinology 1985; 117: 1772-8.
30. Sander M, Bader M, Djavidani B et al. The role of the adrenal gland in the hypertensive transgenic rats TGR(mREN2)27. Endocrinology 1992; 131: 807-14.
31. Djavidani B, Sander M, Kreutz R et al. Chronic dexamethasone treatment suppresses hypertension development in the transgenic rat TGR(mREN2)27. J. Hypertens. 1995; 13: 637-45.
32. Sander M, Ganten D, Mellon SH. Role of adrenal renin in the regulation of adrenal steroidogenesis by corticotropin. Proc. Natl Acad. Sci. USA 1994; 91: 148-52.
33. Yamaguchi T, Tokita Y, Franco-Saenz R, Mulrow PJ, Peters J, Ganten D. Zonal distribution and regulation of adrenal renin in a transgenic model of hypertension in the rat. Endocrinology 1992; 131: 1955-62.
34. Senanayake P, Moriguchi A, Kumagai H, Ganten D, Ferrario CM, Brosnihan KB. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides 1994; 15: 919-26.
35. Moriguchi A, Ferrario CM, Brosnihan KB, Ganten D, Morris M. Differential regulation of central vasopressin in transgenic rats harboring the mouse REN-2 gene. Am. J. Physiol. 1994; 267: R786-91.
36. Lemmer B, Mattes A, Böhm M, Ganten D. Circadian blood pressure variation in transgenic hypertensive rats. Hypertension 1993; 22: 97-101.
37. Lo M, Medeiros IA, Mullins JJ et al. High blood pressure maintenance in transgenic mRen-2 vs Lyon genetically hypertensive rats. Am. J. Physiol. 1993; 265: R180-6.
38. Hirth-Dietrich C, Stasch J-P, Ganten D, Luft FC. Renal effects of captopril and nitrendipine in transgenic rats with an extra renin gene. Hypertension 1994; 23: 626-31.
39. Whitworth CE, Fleming S, Cumming AD et al. Spontaneous development of malignant phase hypertension in transgenic Ren-2 rats. Kidney Int. 1994; 46: 1528-32.
40. Hilgers KF, Peters J, Veelken R et al. Increased vascular angiotensin formation in female rats harboring the mouse Ren-2 gene. Hypertension 1992; 19: 687-91.
41. Anderson S, Brenner BM. Role of intraglomerular hypertension in the initiation and progression of renal disease. In: Kaplan NM, Brenner BM, Laragh JH (eds). The Kidney in Hypertension. Perspectives in Hypertension, vol 1. Raven Press, New York. 1987; 67-76.
42. Villarreal FJ, MacKenna DA, Omens JH, Dillmann WH. Myocardial remodeling in hypertensive Ren-2 transgenic rats. Hypertension 1995; 25: 98-104.
43. Thybo NK, Korsgaard N, Mulvany MJ. Morphology and function of mesenteric resistance arteries in transgenic rats with low-renin hypertension. J. Hypertens. 1992; 10: 1191-6.
44. Mulvany MJ. Resistance vessel structure in hypertension: Growth or remodeling. J. Cardiovasc. Pharmacol. 1993; 22: S44-7.
45. Olivetti G, Melissari M, Marchetti G, Anversa P. Quantitative structural changes of the rat thoracic aorta in early spontaneous hypertension. Circ. Res. 1982; 51: 19-26.
46. Clozel J-P, Kuhn H, Hefti F. Decreases of vascular hypertrophy in four different types of arteries in spontaneously hypertensive rats. Am. J. Med. 1989; 87 (Suppl. 6B): S92-5.
47. Lyall F, Morton JJ, Lever AF, Cragoe EJ. Angiotensin II activates Na-H exchange and stimulates growth in cultured vascular smooth muscle cells. J. Hypertens. 1988; 6 (Suppl. 4): S438-41.
48. Peiro C, Rosa de Sagarra M, Redondo J, Sanchez-Ferrer CF, Marin J. Vascular smooth muscle proliferation in hypertensive transgenic rats. J. Cardiovasc. Pharmacol. 1992; 20 (Suppl. 12): S128-31.
49. Schiffers PMH, Fazzi GE, Jansson GMJ, Uitendaal MP, Struijker Boudier HAJ, De Mey JGR. DNA synthesis in isolated arteries of normotensive and hypertensive rats: Effects of the endothelium. J. Hypertens. 1994; 12: 245-50.
50. Barrett GL, Mullins JJ. Studies on blood pressure regulation in hypertensive ren-2 transgenic rats. Kidney Int. Suppl. 1992; 37: S125-8.
51. Lee M, Böhm M, Kim S et al. Differential gene expression of renin and angiotensinogen in the TGR(mREN-2)27 transgenic rat. Hypertension 1995; 25: 570-80.
52. Böhm M, Lee M, Kreutz R et al. Angiotensin II receptor blockade in TGR(mREN2)27: Effects on renin - angiotensin system gene expression and cardiovascular functions. J. Hypertens. 1995; 13: 891-9.
53. Linz W, Schölkens BA, Ganten D. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin. Exp. Hypertens. [A] 1989; 11: 1325-50.
54. Springate JE, Feld LG, Ganten D. Renal function in hypertensive rats for mouse renin gene. Am. J. Physiol. 1994; 266: F731-7.
55. Ganten D, Lee M, Sander M, Peters J, Bader M, Paul M. The renin gene in hypertension: From molecular analysis to hypertensive transgenic rats. Eur. J. Physiol. 1991; 419 (Suppl. 1): R124 (Abstract).
56. Brosnihan KB, Moriguchi A, Nakamoto H, Dean RH, Ganten D, Ferrario CM. Estrogen augments the contribution of nitric oxide to blood pressure regulation in transgenic hypertensive rats expressing the mouse Ren-2 Gene. Am. J. Hypertens. 1994; 7: 576-82.
57. Bachmann J, Ganten U, Zimmermann F, Mullins JJ, Stock G, Ganten D. Sexual dimorphism of blood pressure in transgenic rats TGR(mREN2)27 harboring the murine Ren-2 gene. In: Sassard J (ed.). Colloque INSERM. Vol. 218, Genetic Hypertension. John Libbey Eurotext, Montrouge. 1992; 353-5.
58. Ganten D, Wagner J, Zeh K et al. Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes. Proc. Natl Acad. Sci. USA 1992; 89: 7806-10.
59. Helene C, Toulme J-J. Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochem. Biophys. Acta 1990; 1049: 99-125.
60. Cotten M, Birnstiel ML. Ribozyme mediated destruction of RNA in vivo. EMBO J. 1989; 8: 3861-6.
61. Katsuki M, Sato M, Kimura M, Yokoyama M, Kobayashi K, Nomura T. Conversion of normal behavior to shiverer by myelin basic protein antisense cDNA in transgenic mice. Science 1988; 241: 593-5.
62. Schinke M, Böhm M, Bricca G, Lippoldt A, Bader M, Ganten D. Antisense RNA expression modulates angiotensinogen synthesis in cell culture and in the brain of transgenic rats. Hypertension 1995; 26: 547 (Abstract).
63. Palmiter RD, Behringer RR, Quaife CJ, Maxwell F, Maxwell FH, Brinster RL. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell 1987; 50: 435-43.
64. Ross SR, Graves RA, Spiegelman BM. Targeted expression of a toxin gene to adipose tissue: Transgenic mice resistant to obesity. Genes Dev. 1993; 7: 1318-24.
65. Borrelli E, Heyman RA, Arias C, Sawchenko PE, Evans RM. Transgenic mice with inducible dwarfism. Nature 1989; 339: 538-41.
66. Heyman RA, Borrelli E, Lesley J et al. Thymidine kinase obliteration: Creation of transgenic mice with controlled immune deficiency. Proc. Natl Acad. Sci. USA 1989; 86: 2698-702.
67. Rossant J, Joyner AL. Towards a molecular-genetic analysis of mammalian development. Trends Genet. 1989; 5: 277-83.
68. Frohman MA, Martin GR. Cut, paste, and save: New approaches to altering specific genes in mice. Cell 1989; 56: 145-7.
69. Capecchi MR. Altering the genome by homologous recombination. Science 1989; 244: 1288-92.
70. LeMoullic H, Lallemand Y, Brúlet P. Targeted replacement of the homeobox gene Hox-3.1 by the Escherichia coli lacZ in mouse chimeric embryos. Proc. Natl Acad. Sci. USA 1990; 87: 4712-16.
71. Tanimoto K, Sugiyama F, Goto Y et al. Angiotensinogen-deficient mice with hypotension. J. Biol. Chem. 1994; 269: 31 334-7.
72. Kim H-S, Krege JH, Kluckman KD et al. Genetic control of blood pressure and the angiotensinogen locus. Proc. Natl Acad. Sci. USA 1995; 92: 2735-9.
73. Krege JH, John SWM, Langenbach LL et al. Male - female differences in fertility and blood pressure in ACE-deficient mice. Nature 1995; 375: 146-8.
74. A angiotensin II receptor gene. Proc. Natl Acad. Sci. USA 1995; 92: 3521-5.
75. A receptor-deficient mice with hypotension and hyperreninemia. J. Biol. Chem. 1995; 270: 18719-22.
76. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature 1995; 377: 744-7.
77. Ichiki T, Labosky PA, Shiota C et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995; 377: 748-50.
78. Miller CCJ, McPheat JC, Potts WJ. Targeted integration of the Ren-1D locus in mouse embryonic stem cells. Proc. Natl Acad. Sci. USA 1992; 89: 5020-4.
79. Gu H, Zou Y-R, Rajewsky K. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-lox P-mediated gene targeting. Cell 1993; 73: 1155-64.
80. Iannaccone PM, Taborn GU, Garton RL, Caplice MD, Brenin DR. Pluripotent embryonic stem cells from the rat are capable of producing chimeras. Dev. Biol. 1994; 163: 288-92.